VACASAN DIN 02560348
Health Canada record
| Active ingredient(s) | TULATHROMYCIN 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | |
| Current status date | 20-Aug-2025 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TULATHROMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02532859 | AROVYN | INTERVET CANADA CORP | Solution | TULATHROMYCIN 100 MG | Approved |
| 02285452 | DRAXXIN | ZOETIS CANADA INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02430711 | DRAXXIN 25 | ZOETIS CANADA INC | Solution | TULATHROMYCIN 25 MG | Marketed |
| 02516683 | DRAXXIN KP | ZOETIS CANADA INC | Solution | TULATHROMYCIN 100 MG; KETOPROFEN 120 MG | Marketed |
| 02516500 | INCREXXA | ELANCO CANADA LIMITED | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02508990 | LYDAXX | VETOQUINOL N A INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02544229 | MACROSYN | BIMEDA-MTC ANIMAL HEALTH INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02536013 | TULAJECT | ALIVIRA ANIMAL HEALTH LIMITED | Solution | TULATHROMYCIN 100 MG | Approved |
| 02502151 | TULAVEN | CEVA ANIMAL HEALTH INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02530155 | TULINOVET | MODERN VETERINARY THERAPEUTICS LLC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02502879 | TULISSIN | VIRBAC AH, INC. | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02536277 | TULISSIN 25 | VIRBAC AH, INC. | Solution | TULATHROMYCIN 25 MG | Approved |
| 02518236 | REXXOLIDE | DECHRA REGULATORY BV | Solution | TULATHROMYCIN 100 MG | Dormant |
| 02505401 | TULIEVE | NORBROOK LABORATORIES LTD. | Solution | TULATHROMYCIN 100 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35860 | 2025-08-20 | Abbreviated New Drug Submission (ANDS) |